EN
HI

ASTEC LIFESCIENCES Share price

ASTEC

704.4

5.25 (-0.74%)
NSE
BSE
Last updated on 28 Apr, 2025 | 15:52 IST
Today's High

693.10

Today's Low

711.95

52 Week Low

1474.40

52 Week High

1474.40

The current prices are delayed, login to your account for live prices

Astec Lifesciences Chart

ASTEC LIFESCIENCES Share Key Metrics

Volume
9275.00
Market Cap
1381.42 CR
LTQ@LTP
2@704.40
ATP
703.94
Var Margin
2264
Circuit Range
567.75-851.55
Delivery %
49.09
Value
65.29 L
ASM/GSM
No
Market Lot
1

ASTEC LIFESCIENCES Futures & Options

Data Not Found

ASTEC LIFESCIENCES Corporate Actions

DateAgenda
2025-07-28-
2025-04-23Audited Results
2025-01-27Quarterly Results
DateEvent TypeAgenda
2025-07-28AGM/EGM-
2025-04-23Board MeetingAudited Results
2025-01-27Board MeetingQuarterly Results

ASTEC LIFESCIENCES News

Astec LifeSciences sinks 11% as Q4 earnings take a knock

May 03 2023 12:25:18
Read More

About ASTEC LIFESCIENCES

NSE : 17728  
BSE : 533138  
ISIN : INE563J01010  

Our Company was incorporated on January 25 1994 under the Companies Act 1956 as UrshilaTraders Private Limited. Our Company was originally promoted by Mrs. Reena Bagai and Mrs.Avita Fernandes. Their shareholding was purchased by Mr. Ashok V Hiremath and Mr. PratapGarud on February 11 1994. The name of our Company was changed to Astec Chemicals PrivateLimited on August 19 1994 and further to Astec LifeSciences Private Limited on March 3 2006.With effect from April 27 2006 Astec LifeSciences Private Limited was converted into a publiclimited company under the name of "Astec LifeSciences Limited".We carry out our manufacturing activities at two locations in Maharashtra India comprising ofthree units in Maharashtra viz. one unit at Dombivli and two units at Mahad (Unit 1 and Unit 2).We started our first manufacturing unit in August 1994 by acquiring a sick unit in DombivliMaharashtra having an installed capacity of 120 MT for the manufacture of Dicap apharmaceutical intermediate.With a view to expand our operations we entered into an agreement with Behram ChemicalsPrivate Limited on February 18 2002 for using and operating their manufacturing facilities locatedat B-16 Mahad Industrial Area Sub-District Mahad District Raigad Maharashtra. BehramChemicals Private Limited was engaged in manufacture of chemicals and pesticides having aninstalled capacity of 130 MT.Behram Chemicals Private Limited was initially promoted by Mr. Jehangir J. Mistry Mrs. Villoo J.Mistry Mrs. Kamla G. Sippy and Mr. Surinder Kumar Verma in April 1993. During August 1998further shares were allotted to M.C. Chemicals and some members of Gangani family viz. Mr.Nasrudin K Gangani Mr. S. N. Gangani Mrs. N. N. Gangani Mr. T. K. Gangani and Khoja BoneMills Private Limited (a company promoted by Gangani family). Looking at the potential inBehram Chemicals Private Limited our Company have acquired 65.63% share by entering intoShare Purchase Agreement with the above members of Gangani family on April 2 2007. Mr.Jehangir J. Mistry Mrs. Villoo J. Mistry Mrs. Kamla G. Sippy and Mr. Surinder Kumar VermaM.C. Chemicals and Gangani family are not related to our Promoters / our Directors in anymanner in any capacity whatsoever. With this acquisition Behram Chemicals Private Limitedbecame a subsidiary of our Company. During 2003-04 we expanded total installed capacity of our units (Dombivli and Mahad) from 250MT to 500 MT. We renewed the agreement on August 1 2004 for a further period of 66 monthsending on January 31 2010. For more details in respect of the current agreement.In 2004 we acquired a plot located at B-17 Mahad Maharashtra and set up a new manufacturingfacility as an Export Oriented Unit (EOU) in the year 2005 (as Unit 2) which is located adjacent toUnit 1 with an installed capacity of 1000 MT. With the commissioning of Unit 2 our total installedcapacity increased to 1500 MT. We further expanded our total capacities to 2000 MT during 2006-07 and to 2500 MT during 2007-08.Our Company is primarily involved in the production of active ingredients and intermediates foragrochemicals and pharmaceutical segment. Hexaconazole Tebuconazole Metalaxyl andPropiconazole are some of our key products in agrochemical segment which are generally used incrop protection and Dicap is one of our key Pharmaceutical intermediate which is used inmanufacture of antifungal agents. Triazole fungicides which includes HexaconazoleTebuconazole and Propiconazole is one of our major product in the agrochemical segment andhas contributed 63.67% to our total sales whereas Dicap a key product in pharmaceutical segmenthas contributed 9.01% during FY 2007-08.Major events of our CompanyPeriod EventsJanuary 1994 Incorporation of Urshila Traders Private LimitedAugust 1994 Change of name to Astec Chemicals Private LimitedAugust 1994 Commenced first manufacturing unit at Dombivli MaharashtraMay 2001 Certified ISO 9002 by International Standards Certification Pty Limited AustraliaFebruary 2002 Entered into an agreement with Behram Chemicals Private LimitedMarch 2005 Re-certified ISO 9001:2000 by International Standards Certification Pty Limited AustraliaMay 2005 Commenced another manufacturing unit (Unit 2) as Export Oriented Unit at Mahad MaharashtraMarch 2006 Change of name to Astec LifeSciences Private LimitedApril 2006 Conversion of our Company from a private limited company to a public limited company January 2007 Established Astec Europe in Tournai BelgiumApril 2007 Behram Chemicals Private Limited became our subsidiary by acquisition of 65.63% vide Share Purchase Agreement dated April 2 2007

ASTEC LIFESCIENCES Management

NamePosition
Mr. Nadir B Godrej Chairman
Mr. Ashok V Hiremath Non Executive Director
Mr. Balram Singh Yadav Non Executive Director
Mr. Anurag Roy Director
Dr. Brahma Nand Vyas Independent Director
Read More

ASTEC LIFESCIENCES FAQs

The Buying Price of ASTEC LIFESCIENCES share is 1403.45 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy ASTEC LIFESCIENCES share to your Choice trading account, or open a Choice Demat account, then add funds, search the company name, select your order type, and place your trade.

The Price-to-earnings (P/E) ratio of ASTEC LIFESCIENCES shares is 0. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio ASTEC LIFESCIENCES shares is 6.19. Useful to assess the stock's value relative to its book value.

To assess ASTEC LIFESCIENCES’s valuation compare Sector P/E, P/B which are 24.1 & 2.73 with sector averages, along with growth rates and financial metrics.

The Market Cap of ASTEC LIFESCIENCES is 1381.42 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of ASTEC LIFESCIENCES share price is 1474.40 & 647.50. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.